about
Hybrid spreading mechanisms and T cell activation shape the dynamics of HIV-1 infectionApolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteinsHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionThe yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNAMurine models of hepatitis C: what can we look forward to?Emerging therapies for the treatment of hepatitis CSolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesUltrastructural analysis of hepatitis C virus particlesGenetic heterogeneity of hepatitis C virus cell entry receptors seems to have no influence on selection of virus variants.Viruses and tetraspanins: lessons from single molecule approaches.Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423Identification of HNRNPK as regulator of hepatitis C virus particle production.Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 CellsSeveral Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released VirusesVirome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and PegivirusesApproaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffoldingApolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C VirusHepatitis C virus infection: Are there still specific problems with genotype 3?Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host RestrictionHepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.New perspectives for preventing hepatitis C virus liver graft infection.CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.How hepatitis C virus invades hepatocytes: the mystery of viral entryThe molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection.An insight into the diagnosis and pathogenesis of hepatitis C virus infection.The past, present and future of neutralizing antibodies for hepatitis C virus.Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus Coinfection.Conserved RNA secondary structures and long-range interactions in hepatitis C viruses.N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.Plant-derived antivirals against hepatitis c virus infection.Signals Involved in Regulation of Hepatitis C Virus RNA Genome Translation and Replication.
P2860
Q21092519-B10E4CB4-1421-4110-998F-6F41959B0E47Q24301976-56059553-5543-49B2-8228-87262A6858E6Q26779128-FBC0B65B-CBD0-4850-8FE6-F31D9023A6A1Q26800446-1847BA83-E61C-4E7D-9891-290B74A329C1Q26991875-3B059938-88C8-4BB1-BD86-F34675F8237EQ27003319-EDECC5B0-2466-42C9-A939-5390F1328263Q27928046-A0344328-DD40-449E-ADAE-126BF4A63C75Q30540507-B074FFD6-B49D-467C-9A51-F50E9E1EB25BQ33556862-C12ED279-626C-40DB-8210-7B067A575B18Q33677540-3B662570-B8C0-4166-88CA-31AC922C6703Q34047477-8A2ACC22-84C4-4DAF-AC63-B642D44328AAQ34875666-230463FD-9351-4057-A2D4-AA3AB3DD0F9DQ35270150-47CE9357-BC2D-4BA4-8622-E57A8267D5EAQ35488198-56DDE28E-B750-4633-AB5F-94F98D1395E6Q35557994-6ABD1004-4801-49BA-BD37-18A8CDC23D38Q35619104-B7BA54F6-10CA-411C-ABB8-A2BB08B8CA2BQ35695028-2F8F0C81-6565-4555-BF89-C1078345B269Q35727227-013C2B0C-0E3D-4DD5-8218-2E120F5BB90FQ35784419-D045D5B6-F1E6-4FA0-8592-DA99D469D4C9Q35942829-B86A9715-DA28-4DAF-BE5D-C39E80E864B9Q36080826-DD835D4D-2F56-4E77-923D-C7DD387A0509Q36269670-5620B276-4519-4FA4-9FE0-AC6F2995CFC4Q36281158-C19BE2EB-ED09-4BD1-B080-410FD50A3D43Q37015738-7067CF2A-BD19-4E41-AA11-A01E33CE780FQ37015805-53A09C09-C038-49B0-8109-C6B0CFD1DA9FQ37611842-AB619FE8-0B51-44B7-8C82-05DF89A310C5Q37682499-417A13EA-98DF-4A00-96A8-A32424C5647AQ38113079-F1747D2B-BF56-433D-91A2-18CB6FDCD7DFQ38168827-783DFAAD-8F51-4241-9999-D13677DD8EEFQ38192357-8AE0F9ED-BCE1-41D9-AD61-5BF6308EF380Q38350416-BD78DD71-4BEF-447A-9095-039CE7AC57E9Q38856649-E921AC76-784C-46D4-A04A-76CB180FC7BEQ39068693-E13F73D5-F2E6-46C8-80BF-9D8FB747DF14Q39380623-EA4D7A59-1325-4939-90EF-014365B36321Q40080738-4AAC80E7-74BA-4063-8579-0D81849665DCQ40949746-DC956DA4-5913-42D6-875E-CD9B61543D8DQ45325110-172000AB-A1C4-4540-87BB-F063A8F60C91Q47238536-637349F6-B7AC-4361-9C4B-E9B1F2B03DBAQ49197977-9CF1947D-3ECE-44AC-B8F0-738CE3260EA9Q54246476-ECA22D88-165A-4056-BF69-AAA04392C008
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatitis C virus entry.
@en
type
label
Hepatitis C virus entry.
@en
prefLabel
Hepatitis C virus entry.
@en
P2093
P1476
Hepatitis C virus entry.
@en
P2093
Daniel J Felmlee
Mirjam B Zeisel
Thomas F Baumert
P304
P356
10.1007/978-3-642-27340-7_4
P577
2013-01-01T00:00:00Z